[Prevention of community-acquired respiratory syncytial virus infections in premature infants: cost-benefit evaluation in the Finistère Department]. [electronic resource]
Producer: 20020412Description: 219-21 p. digitalISSN:- 0929-693X
- Age Factors
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Bronchopulmonary Dysplasia -- complications
- Community-Acquired Infections -- prevention & control
- Cost-Benefit Analysis
- Double-Blind Method
- France
- Hospitalization
- Humans
- Immunization, Passive
- Infant
- Infant, Newborn
- Infant, Premature, Diseases -- economics
- Multicenter Studies as Topic
- Palivizumab
- Placebos
- Prospective Studies
- Randomized Controlled Trials as Topic
- Respiratory Syncytial Virus Infections -- economics
- Retrospective Studies
- Risk Factors
- Seasons
- Time Factors
No physical items for this record
Publication Type: Comparative Study; Letter
There are no comments on this title.
Log in to your account to post a comment.